Paola Bonavolontà

Dr. Paola Bonavolontà

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
GOGiovanni Dell`Aversana Orabona
Giovanni Dell`Aversana Orabona
PBPaola Bonavolontà
Paola Bonavolontà
GIGiorgio Iaconetta
Giorgio Iaconetta
RFRaimondo Forte
Raimondo Forte
LCLuigi Califano
Luigi Califano

1 December 2019 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
PBPaola Bonavolontà
Paola Bonavolontà
GOGiovanni Dell'AVersana Orabona
Giovanni Dell'AVersana Orabona
Fabio MaglittoFabio Maglitto
Fabio Maglitto
VAVincenzo Abbate
Vincenzo Abbate
UCUmberto Committeri
Umberto Committeri
LCLuigi Califano
Luigi Califano

1 June 2018 in Surgical Oncology
Verified
Journal Article
Closed access
GOGiovanni Dell’aVersana Orabona
Giovanni Dell’aVersana Orabona
VAVincenzo Abbate
Vincenzo Abbate
Fabio MaglittoFabio Maglitto
Fabio Maglitto
PBPaola Bonavolontà
Paola Bonavolontà
Giovanni SalzanoGiovanni Salzano
Giovanni Salzano
LCLuigi Califano
Luigi Califano

1 August 2017 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
PBPaola Bonavolontà
Paola Bonavolontà
GOGiovanni Dell`Aversana Orabona
Giovanni Dell`Aversana Orabona
VAVincenzo Abbate
Vincenzo Abbate
Luigi Angelo VairaLuigi Angelo Vaira
Luigi Angelo Vaira
CFCarmelo Lo Faro
Carmelo Lo Faro
LCLuigi Califano
Luigi Califano

1 March 2010 in Ophthalmology
Verified
Journal Article
Closed access
SMSimon N. Madge
Simon N. Madge
KTKrishna Tumuluri
Krishna Tumuluri
DSDiego Strianese
Diego Strianese
PBPaola Bonavolontà
Paola Bonavolontà
GWGeoff Wilcsek
Geoff Wilcsek
DSDinesh Selva
Dinesh Selva

8 January 2014 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
DSDiego Strianese
Diego Strianese
AIAdriana Iuliano
Adriana Iuliano
MFMariantonia Ferrara
Mariantonia Ferrara
CCChiara Comune
Chiara Comune
IBImmacolata Baronissi
Immacolata Baronissi
FTFausto Tranfa
Fausto Tranfa
Background/Aim. To evaluate the efficacy of methotrexate for the treatment of thyroid eye disease (TED).Methods. 36 consecutive patients with active TED, previously treated with corticosteroids but stopped due to the occurrence of side effects, were commenced on methotrexate therapy. Two different weekly doses were administered depending on the weight of the patient (7.5 mg or 10 mg). Clinical activity score (7-CAS), visual acuity (VA), ocular motility, exophthalmos, and eyelid position were retrospectively evaluated at 3, 6, and 12 months and compared with baseline data.Results. There was a statistically significant improvement in 7-CAS at 3, 6, and 12 months after treatment (P<0.0001). There was no significant change in visual acuity. Ocular motility disturbances improved at 6 and 12 months (P<0.001). There was no significant change in exophthalmos (mean 24 mm, SD 3 mm) or eyelid position (marginal reflex distance mean 6 mm, SD 1.5 mm) during the follow-up period. No side effects were registered.Conclusions. Methotrexate therapy is effective in reducing CAS and ocular motility disturbances. No significant improvement in proptosis or eyelid retraction should be expected from this treatment. Eventually, it might be considered a suitable alternative treatment in TED for patients who cannot tolerate steroids.